16 results
P
ovarian cancer patients
I/C
miR-200c, miR-200a, miR-200b, miR-205, miR-145, miR-141, miR-429, and miR-125b, carbohydrate antigen 125
O
diagnostic value
P
men with negative prebiopsy prostate MRI or PI-RADS 3 or Likert 3 lesions
I/C
prostate-specific antigen density (PSAD), gold standard (biopsy pathology)
O
clinically significant prostate cancer (CSPCa)
P
patients with acute pancreatitis
I/C
neutrophil-lymphocyte ratio (NLR), variety of factors
O
severity of acute pancreatitis
P
patients who have undergone cardiac catheterization
I/C
urinary KIM-1 measurement, no intervention or standard care
O
diagnosis of contrast-induced acute kidney injury (CI-AKI)
P
doctors
I/C
artificial intelligence (AI), doctors
O
diagnosis of intracerebral hemorrhage (ICH)
P
newborns
I/C
CK-MM test, genetic testing
O
accuracy
P
heart failure patients
I/C
olprinone, other PDE inhibitors
O
therapeutic effects
P
breast tumors
I/C
superb microvascular imaging (SMI), vascular index (VI)
O
accuracy of diagnosis
P
2662 cases, 8843 controls
I/C
Apolipoprotein E (APOE) test, No limitations on the date
O
Diagnostic value of APOE in Alzheimer's disease
P
patients with suspected rotator cuff tears
I/C
ultrasound diagnosis, arthroscopy or magnetic resonance imaging (MRI) as reference standard
O
diagnostic accuracy, sensitivity, specificity, and post-test probability